A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples